• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[两种甲型肝炎免疫球蛋白预防方法在该感染高发病地区的有效性比较评估]

[Comparative evaluation of the effectiveness of 2 methods of immunoglobulin prophylaxis of hepatitis A in areas with high morbidity in this infection].

作者信息

Gorbunov M A, Sumarokov A A, Iaroshevskaia I Iu, Ikoev V N, Kudriakova R A

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 1984 Aug(8):101-4.

PMID:6237529
Abstract

The article presents the results of a strictly controlled epidemiological experiment on the comparative evaluation of the effectiveness of two methols used for the immunoglobulin prophylaxis of hepatitis A; the simultaneous injection of immunoglobulin to all persons at risk at the beginning of the seasonal rise of morbidity and the injection of the preparation to all persons having contacts with hepatitis A patients in the foci of this infection as such foci appear. These results indicate that in the presence of a sufficiently high morbidity rate the injection of immunoglobulin at the beginning of the seasonal rise of morbidity proved to be most effective. Such use of immunoglobulin made it possible to decrease hepatitis A morbidity 2.1 times in comparison with the control groups and 1.5 times in comparison with the groups receiving the preparation in the foci of infection as such foci appeared.

摘要

本文介绍了一项严格控制的流行病学实验结果,该实验旨在比较两种用于甲型肝炎免疫球蛋白预防的方法的有效性;一种是在发病率季节性上升开始时对所有高危人群同时注射免疫球蛋白,另一种是在甲型肝炎感染疫源地出现时,对所有与甲型肝炎患者有接触的人注射该制剂。这些结果表明,在发病率足够高的情况下,在发病率季节性上升开始时注射免疫球蛋白被证明是最有效的。与对照组相比,这种使用免疫球蛋白的方法使甲型肝炎发病率降低了2.1倍,与在感染疫源地出现时接受该制剂注射的组相比降低了1.5倍。

相似文献

1
[Comparative evaluation of the effectiveness of 2 methods of immunoglobulin prophylaxis of hepatitis A in areas with high morbidity in this infection].[两种甲型肝炎免疫球蛋白预防方法在该感染高发病地区的有效性比较评估]
Zh Mikrobiol Epidemiol Immunobiol. 1984 Aug(8):101-4.
2
[Effect of immunoglobulin prophylaxis on the incidence of the development of anicteric forms of hepatitis A].
Zh Mikrobiol Epidemiol Immunobiol. 1985 Oct(10):57-60.
3
[A trial of using immunoglobulins of known specificity for preventing hepatitis A in regions with high epidemic activity].一项使用已知特异性免疫球蛋白在高流行地区预防甲型肝炎的试验
Zh Mikrobiol Epidemiol Immunobiol. 1990 May(5):56-61.
4
[A trial to decrease hepatitis A morbidity in Dzerzhinsk, Gorki Province].[降低高尔基州捷尔任斯克市甲型肝炎发病率的试验]
Zh Mikrobiol Epidemiol Immunobiol. 1990 Mar(3):52-6.
5
[Evaluation of the effectiveness of a specific immunoglobulin against hepatitis A].[一种特异性抗甲型肝炎免疫球蛋白的有效性评估]
Zh Mikrobiol Epidemiol Immunobiol. 1987 Apr(4):52-5.
6
[Effect of the content of hepatitis A antibodies in immunoglobulin preparations on the effectiveness of the immunoglobulin prophylaxis of hepatitis A].[免疫球蛋白制剂中甲肝抗体含量对甲肝免疫球蛋白预防效果的影响]
Zh Mikrobiol Epidemiol Immunobiol. 1984 Jun(6):86-9.
7
[The evaluation of the late effect of the multiple administration of immunoglobulin on hepatitis A morbidity in organized collectives].[免疫球蛋白多次给药对有组织集体中甲型肝炎发病率远期影响的评估]
Voen Med Zh. 1991 Nov(11):35-7.
8
[Efficiency of normal human immunoglobulins in the prevention of infectious hepatitis].[正常人免疫球蛋白预防传染性肝炎的效果]
Arch Roum Pathol Exp Microbiol. 1968 Dec;27(4):883-92.
9
[Experience with the use of immunoglobulin prophylaxis of hepatitis A in the lithuanian SSR. The prophylactic action of different doses of a commercial immunoglobulin depending on the epidemic situation].[立陶宛苏维埃社会主义共和国甲型肝炎免疫球蛋白预防应用经验。不同剂量市售免疫球蛋白根据疫情的预防作用]
Vopr Virusol. 1982 Mar-Apr;27(2):243-7.
10
[Experience with the use of immunoglobulin prophylaxis of hepatitis A in the Lithuanian SSR. The prophylactic action of different doses of a commercial immunoglobulin in a pre-epidemic period].[立陶宛苏维埃社会主义共和国使用免疫球蛋白预防甲型肝炎的经验。在流行前期不同剂量市售免疫球蛋白的预防作用]
Vopr Virusol. 1982 Mar-Apr;27(2):241-3.